[Pre-Aug 2018] IMSCAR

  1. Cyhoeddwyd

    Design of trials with dying patients: a feasibility study of cluster randomisation versus randomised consent.

    Fowell, A., Johnstone, R., Finlay, I. G., Russell, D. & Russell, I. T., 1 Ion 2006, Yn: Palliative Medicine. 20, 8, t. 799-804

    Allbwn ymchwil: Cyfraniad at gyfnodolynErthygladolygiad gan gymheiriaid

  2. Cyhoeddwyd

    Design of Economic Evaluations of Mindfulness-Based Interventions: Ten Methodological Questions of Which to Be Mindful

    Edwards, R. T., Bryning, L. & Crane, R., 1 Chwef 2014, Yn: Mindfulness. 6, 3, t. 490-500

    Allbwn ymchwil: Cyfraniad at gyfnodolynErthygladolygiad gan gymheiriaid

  3. Cyhoeddwyd

    Dementia and Imagination

    Windle, G., 4 Meh 2014.

    Allbwn ymchwil: Cyfraniad at gynhadleddPapur

  4. Cyhoeddwyd

    Defining rewardable innovation in drug therapy

    Hughes, D., Aronson, J. K., Ferner, R. E. & Hughes, D. A., 1 Ebr 2012, Yn: Nature Reviews Drug Discovery. 11, t. 253-254

    Allbwn ymchwil: Cyfraniad at gyfnodolynErthygladolygiad gan gymheiriaid

  5. Cyhoeddwyd

    Decision-Makers’ Preferences for Approving New Medicines in Wales: A Discrete-Choice Experiment with Assessment of External Validity

    Hughes, D., Linley, W. G. & Hughes, D. A., 1 Ebr 2013, Yn: Pharmacoeconomics. 31, 4, t. 345-355

    Allbwn ymchwil: Cyfraniad at gyfnodolynErthygladolygiad gan gymheiriaid

  6. Cyhoeddwyd

    Data recording aids in acute admissions

    Williams, D., Hoare, D., Shingler, G., Fairweather, C. & Whitaker, C., 1 Ion 2014, Yn: International Journal of Health Care Quality Assurance. 26, 1, t. 6-13

    Allbwn ymchwil: Cyfraniad at gyfnodolynErthygladolygiad gan gymheiriaid

  7. Cyhoeddwyd

    Dabigatran etexilate versus warfarin in management of non-valvular atrial fibrillation in UK context: quantitative benefit-harm and economic analyses

    Hughes, D., Pink, J., Lane, S., Pirmohamed, M. & Hughes D.A., N. V., 31 Hyd 2011, Yn: British Medical Journal. 343, t. 1-14

    Allbwn ymchwil: Cyfraniad at gyfnodolynErthygladolygiad gan gymheiriaid

  8. Cyhoeddwyd

    Current use of pharmacogenetic testing: a national survey of thiopurine methyltransferase testing prior to azathioprine prescription.

    Holmes, E. A., Fargher, E. A., Tricker, K., Newman, W., Elliott, R., Roberts, S. A., Shaffer, J. L., Bruce, I. & Payne, K., 1 Ebr 2007, Yn: Journal of Clinical Pharmacy and Therapeutics. 32, 2, t. 187-195

    Allbwn ymchwil: Cyfraniad at gyfnodolynErthygladolygiad gan gymheiriaid

  9. Cyhoeddwyd

    Current assessment of risk-benefit by regulators: is it time to introduce decision analyses?

    Hughes, D., Hughes, D. A., Bayoumi, A. M. & Pirmohamed, M., 1 Awst 2007, Yn: Clinical Pharmacology and Therapeutics. 82, 2, t. 123-127

    Allbwn ymchwil: Cyfraniad at gyfnodolynErthygladolygiad gan gymheiriaid

  10. Cyhoeddwyd

    Current assessment of risk-benefit by regulators: Is it time to introduce decision analyses?

    Hughes, D., Hughes, D. A., Pirmohamed, M. & Bayoumi, A., 1 Awst 2007.

    Allbwn ymchwil: Cyfraniad at gynhadleddPapur

  11. Cyhoeddwyd

    Cost–effectiveness of pharmacogenetics in anticoagulation: international differences in healthcare systems and costs

    Hughes, D., Verhof, T. I., Redekop, W. K., van Schie, R. M., Bayat, S., Daly, A. K., Geitona, M., Haschke-Becher, E., Hughes, D. A., Kamali, F., Levin, L. A., Manolopoulos, V. G., Pirmohamed, M., Siebert, U., Stingl, J. C., Wadelius, M., de Boer, A. & Maitland-van der Zee, A. H., 1 Medi 2012, Yn: Pharmacogenomics. 13, 12, t. 1405-1417

    Allbwn ymchwil: Cyfraniad at gyfnodolynErthygladolygiad gan gymheiriaid

  12. Cyhoeddwyd

    Costs of non-compliance to antipsychotic medications among patients with schizophrenia.

    Hughes, D., Hughes, D. A., Salas, M., Zuluaga, A., Cowell, W., Lebmeier, M., Vardeva, K., Pisu, M. & Shinogle, J., 1 Mai 2008.

    Allbwn ymchwil: Cyfraniad at gynhadleddPapur

  13. Cyhoeddwyd

    Costs of Medication Nonadherence in Patients with Diabetes Mellitus: A Systematic Review and Critical Analysis of the Literature.

    Hughes, D., Salas, M., Hughes, D. A., Zuluaga, A., Vardeva, K. & Lebmeier, M., 1 Medi 2009, Yn: Value in Health. 12, 6, t. 915-922

    Allbwn ymchwil: Cyfraniad at gyfnodolynErthygladolygiad gan gymheiriaid

  14. Cyhoeddwyd

    Cost-utility analysis of osteopathy in primary care: results from a pragmatic randomized controlled trial.

    Linck, P. G., Russell, I. T., Williams, N. H., Edwards, R. T., Linck, P., Muntz, R., Hibbs, R., Wilkinson, C., Russell, I., Russell, D. & Hounsome, B., 1 Rhag 2004, Yn: Family Practice. 21, 6, t. 643-650

    Allbwn ymchwil: Cyfraniad at gyfnodolynErthygladolygiad gan gymheiriaid

  15. Cyhoeddwyd

    Cost-utility analysis of on-demand rabeprazole and esomeprazole for non-erosive reflux disease

    Hughes, D. & Hughes, D. A., 1 Tach 2003.

    Allbwn ymchwil: Cyfraniad at gynhadleddPapur

  16. Cyhoeddwyd

    Cost-utility analysis of on-demand rabeprazole and esomeprazole for non-erosive reflux disease

    Hughes, D. & Hughes, D. A., 1 Tach 2003.

    Allbwn ymchwil: Cyfraniad at gynhadleddPapur

  17. Cyhoeddwyd

    Cost-utility analysis of on demand rabeprazole and esomeprazole for symptomatic gastro oesophageal reflux disease

    Hughes, D., Hughes, D. A. & Dubois, D., 1 Tach 2003, Yn: Value in Health. 6, 6, t. 613

    Allbwn ymchwil: Cyfraniad at gyfnodolynErthygladolygiad gan gymheiriaid

  18. Cyhoeddwyd

    Cost-effectiveness of steroid (methylprednisolone) injections versus anaesthetic alone for the treatment of Morton’s neuroma: economic evaluation alongside a randomised controlled trial (MortISE trial)

    Edwards, R. T., Yeo, S. T., Russell, D., Thomson, C. E., Beggs, I., Gibson, J. N. A., McMillan, D., Martin, D. J. & Russell, I. T., 25 Chwef 2015, Yn: Journal of Foot and Ankle Research. 8, 6, t. article 6 11 t.

    Allbwn ymchwil: Cyfraniad at gyfnodolynErthygladolygiad gan gymheiriaid

  19. Cyhoeddwyd

    Cost-effectiveness of screening for HLA-A*31:01 prior to initiation of carbamazepine in epilepsy

    Plumpton, C., Yip, V. L. M., Alfirevic, A., Marson, A. G., Pirmohamed, M. & Hughes, D., Ebr 2015, Yn: Epilepsia.

    Allbwn ymchwil: Cyfraniad at gyfnodolynErthygladolygiad gan gymheiriaid

  20. Cyhoeddwyd

    Cost-effectiveness of biological therapy for Crohn's disease: Markov cohort analyses incorporating United Kingdom patient-level cost data.

    Hughes, D., Bodger, K., Kikuchi, T. & Hughes, D. A., 1 Awst 2009, Yn: Alimentary Pharmacology and Therapeutics. 30, 3, t. 265-274

    Allbwn ymchwil: Cyfraniad at gyfnodolynErthygladolygiad gan gymheiriaid

  21. Cyhoeddwyd

    Cost-effectiveness of a national exercise referral programme for primary care patients in Wales: results of a randomised controlled trial

    Linck, P. G., Williams, N. H., Edwards, R. T., Linck, P., Hounsome, N., Raisanen, L., Williams, N., Moore, L. & Murphy, S., 29 Hyd 2013, Yn: BMC Public Health. 13, t. 1021

    Allbwn ymchwil: Cyfraniad at gyfnodolynErthygladolygiad gan gymheiriaid

  22. Cyhoeddwyd

    Cost-effectiveness findings from the Agewell pilot study of behaviour change to promote health and wellbeing in later life

    Jones, C. L., Edwards, R. T., Nelis, S. M., Jones, I. R., Hindle, J. V., Thom, J. M., Cooney, J. & Clare, L., 8 Rhag 2015, Yn: Health Economics and Outcome Research: Open Access. 1, 1

    Allbwn ymchwil: Cyfraniad at gyfnodolynErthygladolygiad gan gymheiriaid

  23. Cyhoeddwyd

    Cost-effectiveness considerations in pharmacogenetics.

    Hughes, D. & Hughes, D. A., 1 Ion 2008.

    Allbwn ymchwil: Cyfraniad at gynhadleddPapur

  24. Cyhoeddwyd

    Cost-effectiveness analysis of infliximab and adalimumab for Crohn's disease.

    Hughes, D., Hughes, D. A., Bodger, K. & Kikuchi, T., 1 Ebr 2008.

    Allbwn ymchwil: Cyfraniad at gynhadleddPapur

  25. Cyhoeddwyd

    Cost-effectiveness analysis of infliximab and adalimumab for Crohn's disease.

    Hughes, D., Hughes, D. A., Bodger, K. & Kikuchi, T., 1 Ebr 2008.

    Allbwn ymchwil: Cyfraniad at gynhadleddPapur

  26. Cyhoeddwyd

    Cost-effectiveness analysis of extended-release formulations of oxybutynin and tolterodine for the management of urge incontinence.

    Hughes, D., Hughes, D. A. & Dubois, D., 1 Ion 2004, Yn: Pharmacoeconomics. 22, 16, t. 1047-1059

    Allbwn ymchwil: Cyfraniad at gyfnodolynErthygladolygiad gan gymheiriaid

  27. Cyhoeddwyd

    Cost-effectiveness analysis of HLA B*5701 genotyping in preventing abacavir hypersensitivity

    Hughes, D., Hughes, D. A., Vilar, F. J., Ward, C. C., Alfirevic, A., Park, B. K. & Pirmohamed, M., 1 Meh 2004, Yn: Pharmacogenetics. 14, 6, t. 335-342

    Allbwn ymchwil: Cyfraniad at gyfnodolynErthygladolygiad gan gymheiriaid

  28. Cyhoeddwyd

    Cost of non-compliance and non-persistence with medications for diabetes mellitus

    Hughes, D., Salas, M., Hughes, D. A., Lebmeier, M. & Vardeva, K., 1 Awst 2007.

    Allbwn ymchwil: Cyfraniad at gynhadleddPapur

  29. Cyhoeddwyd

    Cost minimization of on-demand maintenance therapy with proton pump inhibitors in nonerosive gastroesophageal reflux disease.

    Hughes, D., Hughes, D. A., Marchetti, M. & Colombo, G., 1 Chwef 2005, Yn: Expert Review of Pharmacoeconomics and Outcomes Research. 5, 1, t. 29-38

    Allbwn ymchwil: Cyfraniad at gyfnodolynErthygladolygiad gan gymheiriaid

  30. Cyhoeddwyd

    Cost minimization of on-demand maintenance therapy with proton pump inhibitors in nonerosive gastroesophageal reflux disease

    Hughes, D. & Hughes, D. A., 1 Tach 2004, Yn: Value in Health. 7, 6, t. 753

    Allbwn ymchwil: Cyfraniad at gyfnodolynErthygladolygiad gan gymheiriaid

  31. Cyhoeddwyd

    Cost effectiveness of treatment for alcohol problems: findings of the randomised UK alcohol treatment trial (UKATT)

    Russell, I. T., Orford, J., Alwyn, T., Black, R., Copello, A., Coulton, S., Farrin, A., Godfrey, C., Morton, V., Finnegan, O., Handforth, L., Middleton, W., Raistrick, D., Thistlethwaite, G., Tober, G., Westwood, A., Fryer, K., Heather, N., Hodgson, R., John, B., Kerr, C., Parrott, S., Slegg, G. & Smith, M., 10 Medi 2005, Yn: British Medical Journal. 331, 7516, t. 544-548

    Allbwn ymchwil: Cyfraniad at gyfnodolynErthygladolygiad gan gymheiriaid

  32. Cyhoeddwyd

    Cost effectiveness of pharmacogenetic screening prior to initiation of carbamazepine treatment for epilepsy

    Plumpton, C. O., Yip, V., Alfirevic, A., Marson, A., Pirmohamed, M. & Hughes, D., Tach 2013, Yn: Value in Health. 16, 7, t. A624-A624

    Allbwn ymchwil: Cyfraniad at gyfnodolynErthygladolygiad gan gymheiriaid

  33. Cyhoeddwyd

    Cost and clinical consequence of antibiotic non-adherence in acute exacerbations of chronic bronchitis.

    Sorensen, S. V., Baker, T., Fleurence, R., Dixon, J., Roberts, C., Haider, S. & Hughes, D., 1 Awst 2009, Yn: International Journal of Tuberculosis and Lung Disease. 13, 8, t. 945-954

    Allbwn ymchwil: Cyfraniad at gyfnodolynErthygladolygiad gan gymheiriaid

  34. Cyhoeddwyd

    Continuous subcutaneous insulin infusion compated to multiple daily injection regimens in children and yung people at diagnosis of type 1 diabetes: A pragmatic randomised controlled trial and economic evaluation (scipi trial)

    Blair, J., Mckay, A., Ridyard, C., Thornborough, K., Bedson, E., Peak, M., Didi, M., Annan, F., John, G., Hughes, D. & Gamble, C., Medi 2017, t. 22-23.

    Allbwn ymchwil: Cyfraniad at gynhadleddCrynodebadolygiad gan gymheiriaid

  35. Cyhoeddwyd

    Computerised Multi-media Guided On-line Self-Help Programme.

    Slegg, G. P., Cottrell, S. & Slegg, G., 1 Ion 2009.

    Allbwn ymchwil: Cyfraniad at gynhadleddPapur

  36. Cyhoeddwyd

    Comparisons between the medication possession ratio (MPR) and gaps measures of medication compliance: are we selling ourselves short by relying on the MPR?

    Hughes, D., Nichol, M., Manias, E., Hughes, D. A. & Schabert, V. F., 1 Ion 2009.

    Allbwn ymchwil: Cyfraniad at gynhadleddPapur

  37. Cyhoeddwyd

    Comparison of endovascular aneurysm repair with open repair in patients with abdominal aortic aneurysm (EVAR trial 1), 30-day operative mortality results: randomised controlled trial.

    Russell, I. T. & EVAR trial participants, N. V., 4 Medi 2004, Yn: The Lancet. 364, 9437, t. 843-848

    Allbwn ymchwil: Cyfraniad at gyfnodolynErthygladolygiad gan gymheiriaid

  38. Cyhoeddwyd

    Comparative report on physical health and functional status.

    Ferring, D., Hallberg, I. R., Windle, G., Heiss, C., Paulsson, C., Spazzafumo, L., Borg, C., Van Der Meer, M., Hofman, M. & Petit, C., 1 Ion 2003, 2003 gol. Unknown.

    Allbwn ymchwil: Llyfr/AdroddiadAdroddiad Comisiwn

  39. Cyhoeddwyd

    Comparative assessment of migrant farm worker health in conventional and organic horticultural systems in the United Kingdom.

    Cross, P., Edwards, R. T., Hounsome, B. & Edwards-Jones, G., 25 Chwef 2008, Yn: Science of the Total Environment. 391, 1, t. 55-65

    Allbwn ymchwil: Cyfraniad at gyfnodolynErthygladolygiad gan gymheiriaid

  40. Cyhoeddwyd

    Common, important, and unmet needs of cancer outpatients

    Morrison, V., Henderson, B. J., Zinovieff, F., Davies, G., Cartmell, R., Hall, A. & Gollins, S., 1 Ebr 2012, Yn: European Journal of Oncology Nursing. 16, 2, t. 115-123

    Allbwn ymchwil: Cyfraniad at gyfnodolynErthygladolygiad gan gymheiriaid

  41. Cyhoeddwyd

    Cognitive rehabilitation in dementia: A Special Issue of Neuropsychological Rehabilitation

    Clare, L. (gol.) & Woods, B. (gol.), 19 Gorff 2001, 2001 gol. Psychology Press. 338 t.

    Allbwn ymchwil: Llyfr/AdroddiadLlyfr

  42. Cyhoeddwyd

    Cognitive Reserve in Parkinson’s Disease: The Effects of Welsh-English Bilingualism on Executive Function

    Martin, P. A., Hindle, J. V., Martin-Forbes, P. A., Bastable, A. J., Pye, K. L., Martyr, A., Whitaker, C. J., Craik, F. I., Bialystock, E., Thomas, E. M., Mueller Gathercole, V. C. & Clare, L., 14 Ebr 2015, Yn: Parkinson's Disease. t. 1-10

    Allbwn ymchwil: Cyfraniad at gyfnodolynErthygladolygiad gan gymheiriaid

  43. Cyhoeddwyd

    Cognitive Rehabilitation Changes Memory-Related Brain Activity in People With Alzheimer Disease

    Parkinson, C., Linden, D., van Paasschen, J., Clare, L., Yuen, K. S., Woods, R. T., Evans, S. J., Parkinson, C. H., Rugg, M. D. & Linden D.E.J., N. V., 1 Meh 2013, Yn: Neurorehabilitation and Neural Repair. 27, 5, t. 448-459

    Allbwn ymchwil: Cyfraniad at gyfnodolynErthygladolygiad gan gymheiriaid

  44. Cyhoeddwyd

    Cluster randomised trial of risk communication to enhance informed uptake of cervical screening.

    Russell, I. T., Holloway, R. M., Wilkinson, C., Peters, T. J., Russell, I., Cohen, D., Hale, J., Rogers, C. & Lewis, H., 1 Awst 2003, Yn: British Journal of General Practice. 53, 493, t. 620-625

    Allbwn ymchwil: Cyfraniad at gyfnodolynErthygladolygiad gan gymheiriaid

  45. Cyhoeddwyd

    Clinical guidelines online: do they improve compliance?

    Williams, J. G., Cheung, W. Y., Price, D. E., Tansey, R., Russell, I. T., Duane, P. D., Al-Ismail, S. A. & Wani, M. A., 1 Gorff 2004, Yn: Postgraduate Medical Journal. 80, 945, t. 415-419

    Allbwn ymchwil: Cyfraniad at gyfnodolynErthygladolygiad gan gymheiriaid

  46. Cyhoeddwyd

    Clinical efficacy and mechanistic evaluation of aflibercept for proliferative diabetic retinopathy (acronym CLARITY): a multicentre phase IIb randomised active-controlled clinical trial

    Sivaprasad, S., Prevost, A. T., Bainbridge, J., Edwards, R. T., Hopkins, D., Kelly, J., Luthert, P., Murphy, C., Ramu, J., Sarafraz-Shekary, N., Vasconcelos, J. W. & Hykin, P., 14 Medi 2015, Yn: BMJ Open. 5, 9

    Allbwn ymchwil: Cyfraniad at gyfnodolynErthygladolygiad gan gymheiriaid

  47. Cyhoeddwyd

    Clinical and lay preferences for the explicit prioritisation of elective waiting lists: survey evidence from Wales.

    Edwards, R. T., Boland, A., Wilkinson, C., Cohen, D. & Williams, J., 1 Maw 2003, Yn: Health Policy. 63, 3, t. 229-237

    Allbwn ymchwil: Cyfraniad at gyfnodolynErthygladolygiad gan gymheiriaid

  48. Cyhoeddwyd

    Clinical and econnomic importance of completion of therapy in the treatment of LRTIs

    Hughes, D. & Hughes, D. A., 1 Medi 2006.

    Allbwn ymchwil: Cyfraniad at gynhadleddPapur

  49. Cyhoeddwyd

    Clinical Pharmacology: Special safety considerations in drug development and pharmacovigilance.

    Hughes, D., Atuah, K. N., Hughes, D. A. & Pirmohamed, M., 1 Ion 2004, Yn: Drug Safety. 27, 8, t. 535-554

    Allbwn ymchwil: Cyfraniad at gyfnodolynErthygladolygiad gan gymheiriaid

  50. Cyhoeddwyd

    Clinical Efficacy, Cost-effectiveness and Mechanistic Evaluation of aflibercept for Proliferative Diabetic Retinopathy (acronym CLARITY): a noninferiority randomised trial

    Sivaprasad, S., Hykin, P., Prevost, A. T., Vasconcelos, J., Riddell, A., Ramu, J., Murphy, C., Kelly, J., Edwards, R., Yeo, S. T., Bainbridge, J., Hopkins, D. & White-Alao, B., Ion 2018, NIHR.

    Allbwn ymchwil: Llyfr/AdroddiadAdroddiad Comisiwn